[Two Cases of Peritoneal Dissemination of Gastric Cancer Treated with CART Followed by Chemotherapy]

Gan To Kagaku Ryoho. 2020 Dec;47(13):1887-1889.
[Article in Japanese]

Abstract

Background: Cell-free and concentrated ascites reinfusion therapy(CART)is useful for relief of the symptoms caused by malignant ascites. We experienced 2 cases of untreated gastric cancer with massive ascites due to peritoneal dissemination, to whom chemotherapy was successfully introduced as a result of improvement of general conditions achieved by CART. Case 1: A 56-year-old woman with massive ascites was introduced for the treatment of gastric cancer. After a CART, oral ingestion became possible and S-1 plus oxaliplatin(SOX)therapy was introduced. Three courses of SOX therapy were possible until just before her death with 6 times of maintenance CART in total. Case 2: An 80-year-old man was introduced for the same reason. After a CART, he was treated with 4 courses of trastuzumab plus capecitabine plus oxaliplatin(Tra plus CapeOX)therapy with 5 times of maintenance CART in total.

Discussion: CART is useful for alleviating symptoms caused by malignant ascites and makes systemic chemotherapy possible because it improves and maintains the general conditions.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Ascites / drug therapy
  • Ascites / etiology
  • Capecitabine / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Oxaliplatin / therapeutic use
  • Peritoneal Neoplasms* / drug therapy
  • Stomach Neoplasms* / drug therapy

Substances

  • Oxaliplatin
  • Capecitabine